NetworkNewsBreaks – InMed Pharmaceuticals Inc. (
Post# of 228
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announced that its president and CEO Eric. A. Adams will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The event is slated to be held virtually from Sept. 13-15, 2021. Adams’ presentation will be available on-demand beginning at 1:00 p.m. ET on Sept. 13, accessible from the H.C. Wainwright events platform at HCW Events. An archived replay will be available on the company’s website immediately following the conference for a period of 90 days. In addition, InMed’s management team will be conducting meetings with institutional investors throughout the event. Interested parties should contact their H.C. Wainwright representative to schedule a meeting or register for the conference at HCW Events.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer